0

Close
 
Upcoming Allied Market Research
2023
Fungal Testing Kits Market

Fungal Testing Kits Market

by Test Type (Molecular Test, Chromogenic Test, Others), by Sample Type (Skin, Urine, Vaginal Secretion, Blood, Others), by Application (Research, Susceptibility Testing, Medical Diagnosis, Others) and by End User (Diagnostic Laboratories, Hospitals and Clinics, Research Institutes, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Diagnostics and Biotech
Report Code: A12324
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Fungal Testing Kits Market

Request Now !

Fungal testing kit is used as a fungal infection diagnostic kit in clinics, hospitals, and diagnostic centers. This kit is a serological assay that helps in qualitatively detecting beta-glucan in the serum of a patient who is showing symptoms of invasive fungal infections. Beta-glucans are polysaccharides found in the cell wall of fungi. By detecting a fungal infection, healthcare professionals can prescribe treatment for the specific fungi type. The sample collected by fungal testing kits is taken from body fluids, blood, scrapings of skin, nail,  hair, or tissues . Tissue samples are taken for biopsy when there are symptoms of a deep infection.

COVID-19 Impact Analysis

COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in December, 2019. This highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since its outbreak, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

At the early phase of the COVID-19 pandemic, there was no availability of any specific diagnostic test to detect the disease in patients. Alternative diagnostic tests were used initially but were not much effective. This unavailability of specific COVID-19 diagnostic tests presented lucrative opportunities for diagnostic manufacturers to introduce their COVID-19 diagnostic kits. Many leading players as well as some start-ups from various countries utilized this opportunity and introduced COVID-19 diagnostics kits into local as well as global markets. These players achieved an edge over other diagnostics players, capitalizing on the opportunity from demand for COVID-19 diagnostic tests, which, in turn, helped them in maintaining their revenue in such a crisis.

However, with COVID-19, the supply chain of the raw material required to manufacture fungal testing kits and products for Down syndrome was disrupted in many countries. In addition, the market growth of diagnostic products is also declining as the manufacturers of diagnostic kits have slowed down their production because of the pandemic. This, in turn, is expected to have a significant impact on the fungal testing kits market.

Top Impacting Factors

  • The geriatric population has witnessed immense proliferation all across the world. The vulnerability of aged people to fungal infections is quite high. This factor has helped to boost the market of fungal testing kits.
  • In addition, with an increase in population worldwide, the number of hospital admissions has increased. With rise in number of people, the chances of infections getting spread are also high. Hence, this can also help grow the fungal testing kits market.
  • There are many fungal infections that can be fatal for humans, such as black fungus infection. For this reason, governments all across the world are increasing investments in manufacturing fungal testing kits. This will positively influence the fungal testing kits market growth during the forecast period.
  • However, there are many conservative social and cultural perceptions about certain diseases that can hinder the growth of the fungal testing kits market. This is because most fungal infections affect the genitals. Countries like Mexico, South Africa, and Colombia have a conservative outlook combating genital disorders making people reluctant to seek diagnosis and treatment for them. This can hamper fungal testing kits market growth.

Key Market Trends

Players such as GenMark Diagnostics, Inc. and La-Roche have released serological assays in the market such as the COBAT LIAT PCR system. This system consists of ePlex blood culture identification panel serological assay to help identify fungal infection subtypes.

In 2019, the acquisition of Brammer Bio was announced by Thermo Fisher Scientific. This acquisition helped Thermo Fisher Scientific enhance its laboratory services and product portfolio for fungal testing kits.

North America has emerged as the global leader in the fungal testing kits market. This can be attributed to the high prevalence of infectious diseases. In addition, the awareness regarding various fungal diseases has also escalated in this region which has increased the need for fungal testing kits.

In Asia-Pacific, the fungal testing kits market is expected to grow in countries like South Korea, China, India, and Japan. These nations represent growth potential in the wake of increasing healthcare expenditure and a huge patient pool. Infections such as invasive fungal diseases and candidiasis are also rampant in these aforementioned nations. This boosts the growth of the fungal testing kits market.

Key Benefits of the Report

  • This study presents the analytical depiction of the fungal testing kits industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the fungal testing kits market share.
  • The current market is quantitatively analyzed to highlight the growth scenario of the fungal testing kits market.
  • Porter’s five forces analysis illustrates the potency of buyers and suppliers in the market.
  • The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.

Questions Answered in the Fungal Testing Kits Report

  • Which are the leading players active in the fungal testing kits market?
  • How is each segment of the market expected to grow during the forecast period?
  • What are the adoption trends for the fungal testing kits market in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps in the market?
  • What are the impacts of COVID-19 on the industry?
  • What are fungal testing kits?
  • What are the current and predicted trends of the market?

 Fungal Testing Kits Market Report Highlights

Aspects Details
By Test Type
  • Molecular Test
  • Chromogenic Test
  • Others
By Sample Type
  • Skin
  • Urine
  • Vaginal Secretion
  • Blood
  • Others
By Application
  • Research
  • Susceptibility Testing
  • Medical Diagnosis
  • Others
By End User
  • Diagnostic Laboratories
  • Hospitals and Clinics
  • Research Institutes
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players F. Hoffman La-Roche Ltd., Norgen Biotek, Merck KGaA, ELITech Group, Biomed Diagnostics, Inc., Hologic, Inc., PerkinElmer, Thermo Fisher Scientific, bioMerieux SA, C.P.M Diagnostic Research SAS
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: FUNGAL TESTING KITS MARKET, BY TEST TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Test Type

    • 4.2. Molecular Test

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Chromogenic Test

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Others

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: FUNGAL TESTING KITS MARKET, BY SAMPLE TYPE

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Sample Type

    • 5.2. Skin

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Urine

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Vaginal Secretion

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Blood

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Others

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

  • CHAPTER 6: FUNGAL TESTING KITS MARKET, BY APPLICATION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Application

    • 6.2. Research

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Susceptibility Testing

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Medical Diagnosis

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Others

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

  • CHAPTER 7: FUNGAL TESTING KITS MARKET, BY END USER

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By End User

    • 7.2. Diagnostic Laboratories

      • 7.2.1. Key Market Trends, Growth Factors and Opportunities

      • 7.2.2. Market Size and Forecast, By Region

      • 7.2.3. Market Share Analysis, By Country

    • 7.3. Hospitals And Clinics

      • 7.3.1. Key Market Trends, Growth Factors and Opportunities

      • 7.3.2. Market Size and Forecast, By Region

      • 7.3.3. Market Share Analysis, By Country

    • 7.4. Research Institutes

      • 7.4.1. Key Market Trends, Growth Factors and Opportunities

      • 7.4.2. Market Size and Forecast, By Region

      • 7.4.3. Market Share Analysis, By Country

    • 7.5. Others

      • 7.5.1. Key Market Trends, Growth Factors and Opportunities

      • 7.5.2. Market Size and Forecast, By Region

      • 7.5.3. Market Share Analysis, By Country

  • CHAPTER 8: FUNGAL TESTING KITS MARKET, BY REGION

    • 8.1. Market Overview

      • 8.1.1 Market Size and Forecast, By Region

    • 8.2. North America

      • 8.2.1. Key Market Trends and Opportunities

      • 8.2.2. Market Size and Forecast, By Test Type

      • 8.2.3. Market Size and Forecast, By Sample Type

      • 8.2.4. Market Size and Forecast, By Application

      • 8.2.5. Market Size and Forecast, By End User

      • 8.2.6. Market Size and Forecast, By Country

      • 8.2.7. U.S. Fungal Testing Kits Market

        • 8.2.7.1. Market Size and Forecast, By Test Type
        • 8.2.7.2. Market Size and Forecast, By Sample Type
        • 8.2.7.3. Market Size and Forecast, By Application
        • 8.2.7.4. Market Size and Forecast, By End User

      • 8.2.8. Canada Fungal Testing Kits Market

        • 8.2.8.1. Market Size and Forecast, By Test Type
        • 8.2.8.2. Market Size and Forecast, By Sample Type
        • 8.2.8.3. Market Size and Forecast, By Application
        • 8.2.8.4. Market Size and Forecast, By End User

      • 8.2.9. Mexico Fungal Testing Kits Market

        • 8.2.9.1. Market Size and Forecast, By Test Type
        • 8.2.9.2. Market Size and Forecast, By Sample Type
        • 8.2.9.3. Market Size and Forecast, By Application
        • 8.2.9.4. Market Size and Forecast, By End User

    • 8.3. Europe

      • 8.3.1. Key Market Trends and Opportunities

      • 8.3.2. Market Size and Forecast, By Test Type

      • 8.3.3. Market Size and Forecast, By Sample Type

      • 8.3.4. Market Size and Forecast, By Application

      • 8.3.5. Market Size and Forecast, By End User

      • 8.3.6. Market Size and Forecast, By Country

      • 8.3.7. France Fungal Testing Kits Market

        • 8.3.7.1. Market Size and Forecast, By Test Type
        • 8.3.7.2. Market Size and Forecast, By Sample Type
        • 8.3.7.3. Market Size and Forecast, By Application
        • 8.3.7.4. Market Size and Forecast, By End User

      • 8.3.8. Germany Fungal Testing Kits Market

        • 8.3.8.1. Market Size and Forecast, By Test Type
        • 8.3.8.2. Market Size and Forecast, By Sample Type
        • 8.3.8.3. Market Size and Forecast, By Application
        • 8.3.8.4. Market Size and Forecast, By End User

      • 8.3.9. Italy Fungal Testing Kits Market

        • 8.3.9.1. Market Size and Forecast, By Test Type
        • 8.3.9.2. Market Size and Forecast, By Sample Type
        • 8.3.9.3. Market Size and Forecast, By Application
        • 8.3.9.4. Market Size and Forecast, By End User

      • 8.3.10. Spain Fungal Testing Kits Market

        • 8.3.10.1. Market Size and Forecast, By Test Type
        • 8.3.10.2. Market Size and Forecast, By Sample Type
        • 8.3.10.3. Market Size and Forecast, By Application
        • 8.3.10.4. Market Size and Forecast, By End User

      • 8.3.11. UK Fungal Testing Kits Market

        • 8.3.11.1. Market Size and Forecast, By Test Type
        • 8.3.11.2. Market Size and Forecast, By Sample Type
        • 8.3.11.3. Market Size and Forecast, By Application
        • 8.3.11.4. Market Size and Forecast, By End User

      • 8.3.12. Russia Fungal Testing Kits Market

        • 8.3.12.1. Market Size and Forecast, By Test Type
        • 8.3.12.2. Market Size and Forecast, By Sample Type
        • 8.3.12.3. Market Size and Forecast, By Application
        • 8.3.12.4. Market Size and Forecast, By End User

      • 8.3.13. Rest Of Europe Fungal Testing Kits Market

        • 8.3.13.1. Market Size and Forecast, By Test Type
        • 8.3.13.2. Market Size and Forecast, By Sample Type
        • 8.3.13.3. Market Size and Forecast, By Application
        • 8.3.13.4. Market Size and Forecast, By End User

    • 8.4. Asia-Pacific

      • 8.4.1. Key Market Trends and Opportunities

      • 8.4.2. Market Size and Forecast, By Test Type

      • 8.4.3. Market Size and Forecast, By Sample Type

      • 8.4.4. Market Size and Forecast, By Application

      • 8.4.5. Market Size and Forecast, By End User

      • 8.4.6. Market Size and Forecast, By Country

      • 8.4.7. China Fungal Testing Kits Market

        • 8.4.7.1. Market Size and Forecast, By Test Type
        • 8.4.7.2. Market Size and Forecast, By Sample Type
        • 8.4.7.3. Market Size and Forecast, By Application
        • 8.4.7.4. Market Size and Forecast, By End User

      • 8.4.8. Japan Fungal Testing Kits Market

        • 8.4.8.1. Market Size and Forecast, By Test Type
        • 8.4.8.2. Market Size and Forecast, By Sample Type
        • 8.4.8.3. Market Size and Forecast, By Application
        • 8.4.8.4. Market Size and Forecast, By End User

      • 8.4.9. India Fungal Testing Kits Market

        • 8.4.9.1. Market Size and Forecast, By Test Type
        • 8.4.9.2. Market Size and Forecast, By Sample Type
        • 8.4.9.3. Market Size and Forecast, By Application
        • 8.4.9.4. Market Size and Forecast, By End User

      • 8.4.10. South Korea Fungal Testing Kits Market

        • 8.4.10.1. Market Size and Forecast, By Test Type
        • 8.4.10.2. Market Size and Forecast, By Sample Type
        • 8.4.10.3. Market Size and Forecast, By Application
        • 8.4.10.4. Market Size and Forecast, By End User

      • 8.4.11. Australia Fungal Testing Kits Market

        • 8.4.11.1. Market Size and Forecast, By Test Type
        • 8.4.11.2. Market Size and Forecast, By Sample Type
        • 8.4.11.3. Market Size and Forecast, By Application
        • 8.4.11.4. Market Size and Forecast, By End User

      • 8.4.12. Thailand Fungal Testing Kits Market

        • 8.4.12.1. Market Size and Forecast, By Test Type
        • 8.4.12.2. Market Size and Forecast, By Sample Type
        • 8.4.12.3. Market Size and Forecast, By Application
        • 8.4.12.4. Market Size and Forecast, By End User

      • 8.4.13. Malaysia Fungal Testing Kits Market

        • 8.4.13.1. Market Size and Forecast, By Test Type
        • 8.4.13.2. Market Size and Forecast, By Sample Type
        • 8.4.13.3. Market Size and Forecast, By Application
        • 8.4.13.4. Market Size and Forecast, By End User

      • 8.4.14. Indonesia Fungal Testing Kits Market

        • 8.4.14.1. Market Size and Forecast, By Test Type
        • 8.4.14.2. Market Size and Forecast, By Sample Type
        • 8.4.14.3. Market Size and Forecast, By Application
        • 8.4.14.4. Market Size and Forecast, By End User

      • 8.4.15. Rest of Asia Pacific Fungal Testing Kits Market

        • 8.4.15.1. Market Size and Forecast, By Test Type
        • 8.4.15.2. Market Size and Forecast, By Sample Type
        • 8.4.15.3. Market Size and Forecast, By Application
        • 8.4.15.4. Market Size and Forecast, By End User

    • 8.5. LAMEA

      • 8.5.1. Key Market Trends and Opportunities

      • 8.5.2. Market Size and Forecast, By Test Type

      • 8.5.3. Market Size and Forecast, By Sample Type

      • 8.5.4. Market Size and Forecast, By Application

      • 8.5.5. Market Size and Forecast, By End User

      • 8.5.6. Market Size and Forecast, By Country

      • 8.5.7. Brazil Fungal Testing Kits Market

        • 8.5.7.1. Market Size and Forecast, By Test Type
        • 8.5.7.2. Market Size and Forecast, By Sample Type
        • 8.5.7.3. Market Size and Forecast, By Application
        • 8.5.7.4. Market Size and Forecast, By End User

      • 8.5.8. South Africa Fungal Testing Kits Market

        • 8.5.8.1. Market Size and Forecast, By Test Type
        • 8.5.8.2. Market Size and Forecast, By Sample Type
        • 8.5.8.3. Market Size and Forecast, By Application
        • 8.5.8.4. Market Size and Forecast, By End User

      • 8.5.9. Saudi Arabia Fungal Testing Kits Market

        • 8.5.9.1. Market Size and Forecast, By Test Type
        • 8.5.9.2. Market Size and Forecast, By Sample Type
        • 8.5.9.3. Market Size and Forecast, By Application
        • 8.5.9.4. Market Size and Forecast, By End User

      • 8.5.10. UAE Fungal Testing Kits Market

        • 8.5.10.1. Market Size and Forecast, By Test Type
        • 8.5.10.2. Market Size and Forecast, By Sample Type
        • 8.5.10.3. Market Size and Forecast, By Application
        • 8.5.10.4. Market Size and Forecast, By End User

      • 8.5.11. Argentina Fungal Testing Kits Market

        • 8.5.11.1. Market Size and Forecast, By Test Type
        • 8.5.11.2. Market Size and Forecast, By Sample Type
        • 8.5.11.3. Market Size and Forecast, By Application
        • 8.5.11.4. Market Size and Forecast, By End User

      • 8.5.12. Rest of LAMEA Fungal Testing Kits Market

        • 8.5.12.1. Market Size and Forecast, By Test Type
        • 8.5.12.2. Market Size and Forecast, By Sample Type
        • 8.5.12.3. Market Size and Forecast, By Application
        • 8.5.12.4. Market Size and Forecast, By End User

  • CHAPTER 9: COMPETITIVE LANDSCAPE

    • 9.1. Introduction

    • 9.2. Top Winning Strategies

    • 9.3. Product Mapping Of Top 10 Player

    • 9.4. Competitive Dashboard

    • 9.5. Competitive Heatmap

    • 9.6. Top Player Positioning,2022

  • CHAPTER 10: COMPANY PROFILES

    • 10.1. Merck KGaA

      • 10.1.1. Company Overview

      • 10.1.2. Key Executives

      • 10.1.3. Company Snapshot

      • 10.1.4. Operating Business Segments

      • 10.1.5. Product Portfolio

      • 10.1.6. Business Performance

      • 10.1.7. Key Strategic Moves and Developments

    • 10.2. Thermo Fisher Scientific

      • 10.2.1. Company Overview

      • 10.2.2. Key Executives

      • 10.2.3. Company Snapshot

      • 10.2.4. Operating Business Segments

      • 10.2.5. Product Portfolio

      • 10.2.6. Business Performance

      • 10.2.7. Key Strategic Moves and Developments

    • 10.3. BioMerieux SA

      • 10.3.1. Company Overview

      • 10.3.2. Key Executives

      • 10.3.3. Company Snapshot

      • 10.3.4. Operating Business Segments

      • 10.3.5. Product Portfolio

      • 10.3.6. Business Performance

      • 10.3.7. Key Strategic Moves and Developments

    • 10.4. ELITech Group

      • 10.4.1. Company Overview

      • 10.4.2. Key Executives

      • 10.4.3. Company Snapshot

      • 10.4.4. Operating Business Segments

      • 10.4.5. Product Portfolio

      • 10.4.6. Business Performance

      • 10.4.7. Key Strategic Moves and Developments

    • 10.5. PerkinElmer

      • 10.5.1. Company Overview

      • 10.5.2. Key Executives

      • 10.5.3. Company Snapshot

      • 10.5.4. Operating Business Segments

      • 10.5.5. Product Portfolio

      • 10.5.6. Business Performance

      • 10.5.7. Key Strategic Moves and Developments

    • 10.6. Norgen Biotek

      • 10.6.1. Company Overview

      • 10.6.2. Key Executives

      • 10.6.3. Company Snapshot

      • 10.6.4. Operating Business Segments

      • 10.6.5. Product Portfolio

      • 10.6.6. Business Performance

      • 10.6.7. Key Strategic Moves and Developments

    • 10.7. C.P.M Diagnostic Research SAS

      • 10.7.1. Company Overview

      • 10.7.2. Key Executives

      • 10.7.3. Company Snapshot

      • 10.7.4. Operating Business Segments

      • 10.7.5. Product Portfolio

      • 10.7.6. Business Performance

      • 10.7.7. Key Strategic Moves and Developments

    • 10.8. Biomed Diagnostics, Inc.

      • 10.8.1. Company Overview

      • 10.8.2. Key Executives

      • 10.8.3. Company Snapshot

      • 10.8.4. Operating Business Segments

      • 10.8.5. Product Portfolio

      • 10.8.6. Business Performance

      • 10.8.7. Key Strategic Moves and Developments

    • 10.9. F. Hoffman La-Roche Ltd.

      • 10.9.1. Company Overview

      • 10.9.2. Key Executives

      • 10.9.3. Company Snapshot

      • 10.9.4. Operating Business Segments

      • 10.9.5. Product Portfolio

      • 10.9.6. Business Performance

      • 10.9.7. Key Strategic Moves and Developments

    • 10.10. Hologic, Inc.

      • 10.10.1. Company Overview

      • 10.10.2. Key Executives

      • 10.10.3. Company Snapshot

      • 10.10.4. Operating Business Segments

      • 10.10.5. Product Portfolio

      • 10.10.6. Business Performance

      • 10.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL FUNGAL TESTING KITS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL FUNGAL TESTING KITS MARKET FOR MOLECULAR TEST, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL FUNGAL TESTING KITS MARKET FOR CHROMOGENIC TEST, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL FUNGAL TESTING KITS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL FUNGAL TESTING KITS MARKET, BY SAMPLE TYPE, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL FUNGAL TESTING KITS MARKET FOR SKIN, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL FUNGAL TESTING KITS MARKET FOR URINE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL FUNGAL TESTING KITS MARKET FOR VAGINAL SECRETION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL FUNGAL TESTING KITS MARKET FOR BLOOD, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL FUNGAL TESTING KITS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL FUNGAL TESTING KITS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL FUNGAL TESTING KITS MARKET FOR RESEARCH, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL FUNGAL TESTING KITS MARKET FOR SUSCEPTIBILITY TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL FUNGAL TESTING KITS MARKET FOR MEDICAL DIAGNOSIS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL FUNGAL TESTING KITS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL FUNGAL TESTING KITS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 17. GLOBAL FUNGAL TESTING KITS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. GLOBAL FUNGAL TESTING KITS MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. GLOBAL FUNGAL TESTING KITS MARKET FOR RESEARCH INSTITUTES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. GLOBAL FUNGAL TESTING KITS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. GLOBAL FUNGAL TESTING KITS MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 22. NORTH AMERICA FUNGAL TESTING KITS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 23. NORTH AMERICA FUNGAL TESTING KITS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 24. NORTH AMERICA FUNGAL TESTING KITS, BY SAMPLE TYPE, 2022-2032 ($MILLION)
  • TABLE 25. NORTH AMERICA FUNGAL TESTING KITS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 26. NORTH AMERICA FUNGAL TESTING KITS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 27. U.S. FUNGAL TESTING KITS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 28. U.S. FUNGAL TESTING KITS, BY SAMPLE TYPE, 2022-2032 ($MILLION)
  • TABLE 29. U.S. FUNGAL TESTING KITS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 30. U.S. FUNGAL TESTING KITS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 31. CANADA FUNGAL TESTING KITS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 32. CANADA FUNGAL TESTING KITS, BY SAMPLE TYPE, 2022-2032 ($MILLION)
  • TABLE 33. CANADA FUNGAL TESTING KITS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 34. CANADA FUNGAL TESTING KITS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 35. MEXICO FUNGAL TESTING KITS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 36. MEXICO FUNGAL TESTING KITS, BY SAMPLE TYPE, 2022-2032 ($MILLION)
  • TABLE 37. MEXICO FUNGAL TESTING KITS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 38. MEXICO FUNGAL TESTING KITS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 39. EUROPE FUNGAL TESTING KITS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 40. EUROPE FUNGAL TESTING KITS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 41. EUROPE FUNGAL TESTING KITS, BY SAMPLE TYPE, 2022-2032 ($MILLION)
  • TABLE 42. EUROPE FUNGAL TESTING KITS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 43. EUROPE FUNGAL TESTING KITS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 44. FRANCE FUNGAL TESTING KITS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 45. FRANCE FUNGAL TESTING KITS, BY SAMPLE TYPE, 2022-2032 ($MILLION)
  • TABLE 46. FRANCE FUNGAL TESTING KITS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 47. FRANCE FUNGAL TESTING KITS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 48. GERMANY FUNGAL TESTING KITS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 49. GERMANY FUNGAL TESTING KITS, BY SAMPLE TYPE, 2022-2032 ($MILLION)
  • TABLE 50. GERMANY FUNGAL TESTING KITS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 51. GERMANY FUNGAL TESTING KITS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 52. ITALY FUNGAL TESTING KITS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 53. ITALY FUNGAL TESTING KITS, BY SAMPLE TYPE, 2022-2032 ($MILLION)
  • TABLE 54. ITALY FUNGAL TESTING KITS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 55. ITALY FUNGAL TESTING KITS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 56. SPAIN FUNGAL TESTING KITS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 57. SPAIN FUNGAL TESTING KITS, BY SAMPLE TYPE, 2022-2032 ($MILLION)
  • TABLE 58. SPAIN FUNGAL TESTING KITS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 59. SPAIN FUNGAL TESTING KITS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 60. UK FUNGAL TESTING KITS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 61. UK FUNGAL TESTING KITS, BY SAMPLE TYPE, 2022-2032 ($MILLION)
  • TABLE 62. UK FUNGAL TESTING KITS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 63. UK FUNGAL TESTING KITS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 64. RUSSIA FUNGAL TESTING KITS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 65. RUSSIA FUNGAL TESTING KITS, BY SAMPLE TYPE, 2022-2032 ($MILLION)
  • TABLE 66. RUSSIA FUNGAL TESTING KITS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 67. RUSSIA FUNGAL TESTING KITS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 68. REST OF EUROPE FUNGAL TESTING KITS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 69. REST OF EUROPE FUNGAL TESTING KITS, BY SAMPLE TYPE, 2022-2032 ($MILLION)
  • TABLE 70. REST OF EUROPE FUNGAL TESTING KITS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 71. REST OF EUROPE FUNGAL TESTING KITS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 72. ASIA-PACIFIC FUNGAL TESTING KITS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 73. ASIA-PACIFIC FUNGAL TESTING KITS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 74. ASIA-PACIFIC FUNGAL TESTING KITS, BY SAMPLE TYPE, 2022-2032 ($MILLION)
  • TABLE 75. ASIA-PACIFIC FUNGAL TESTING KITS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 76. ASIA-PACIFIC FUNGAL TESTING KITS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 77. CHINA FUNGAL TESTING KITS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 78. CHINA FUNGAL TESTING KITS, BY SAMPLE TYPE, 2022-2032 ($MILLION)
  • TABLE 79. CHINA FUNGAL TESTING KITS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 80. CHINA FUNGAL TESTING KITS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 81. JAPAN FUNGAL TESTING KITS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 82. JAPAN FUNGAL TESTING KITS, BY SAMPLE TYPE, 2022-2032 ($MILLION)
  • TABLE 83. JAPAN FUNGAL TESTING KITS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 84. JAPAN FUNGAL TESTING KITS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 85. INDIA FUNGAL TESTING KITS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 86. INDIA FUNGAL TESTING KITS, BY SAMPLE TYPE, 2022-2032 ($MILLION)
  • TABLE 87. INDIA FUNGAL TESTING KITS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 88. INDIA FUNGAL TESTING KITS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 89. SOUTH KOREA FUNGAL TESTING KITS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 90. SOUTH KOREA FUNGAL TESTING KITS, BY SAMPLE TYPE, 2022-2032 ($MILLION)
  • TABLE 91. SOUTH KOREA FUNGAL TESTING KITS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 92. SOUTH KOREA FUNGAL TESTING KITS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 93. AUSTRALIA FUNGAL TESTING KITS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 94. AUSTRALIA FUNGAL TESTING KITS, BY SAMPLE TYPE, 2022-2032 ($MILLION)
  • TABLE 95. AUSTRALIA FUNGAL TESTING KITS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 96. AUSTRALIA FUNGAL TESTING KITS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 97. THAILAND FUNGAL TESTING KITS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 98. THAILAND FUNGAL TESTING KITS, BY SAMPLE TYPE, 2022-2032 ($MILLION)
  • TABLE 99. THAILAND FUNGAL TESTING KITS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 100. THAILAND FUNGAL TESTING KITS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 101. MALAYSIA FUNGAL TESTING KITS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 102. MALAYSIA FUNGAL TESTING KITS, BY SAMPLE TYPE, 2022-2032 ($MILLION)
  • TABLE 103. MALAYSIA FUNGAL TESTING KITS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 104. MALAYSIA FUNGAL TESTING KITS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 105. INDONESIA FUNGAL TESTING KITS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 106. INDONESIA FUNGAL TESTING KITS, BY SAMPLE TYPE, 2022-2032 ($MILLION)
  • TABLE 107. INDONESIA FUNGAL TESTING KITS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 108. INDONESIA FUNGAL TESTING KITS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 109. REST OF ASIA PACIFIC FUNGAL TESTING KITS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 110. REST OF ASIA PACIFIC FUNGAL TESTING KITS, BY SAMPLE TYPE, 2022-2032 ($MILLION)
  • TABLE 111. REST OF ASIA PACIFIC FUNGAL TESTING KITS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 112. REST OF ASIA PACIFIC FUNGAL TESTING KITS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 113. LAMEA FUNGAL TESTING KITS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 114. LAMEA FUNGAL TESTING KITS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 115. LAMEA FUNGAL TESTING KITS, BY SAMPLE TYPE, 2022-2032 ($MILLION)
  • TABLE 116. LAMEA FUNGAL TESTING KITS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 117. LAMEA FUNGAL TESTING KITS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 118. BRAZIL FUNGAL TESTING KITS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 119. BRAZIL FUNGAL TESTING KITS, BY SAMPLE TYPE, 2022-2032 ($MILLION)
  • TABLE 120. BRAZIL FUNGAL TESTING KITS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 121. BRAZIL FUNGAL TESTING KITS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 122. SOUTH AFRICA FUNGAL TESTING KITS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 123. SOUTH AFRICA FUNGAL TESTING KITS, BY SAMPLE TYPE, 2022-2032 ($MILLION)
  • TABLE 124. SOUTH AFRICA FUNGAL TESTING KITS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 125. SOUTH AFRICA FUNGAL TESTING KITS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 126. SAUDI ARABIA FUNGAL TESTING KITS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 127. SAUDI ARABIA FUNGAL TESTING KITS, BY SAMPLE TYPE, 2022-2032 ($MILLION)
  • TABLE 128. SAUDI ARABIA FUNGAL TESTING KITS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 129. SAUDI ARABIA FUNGAL TESTING KITS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 130. UAE FUNGAL TESTING KITS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 131. UAE FUNGAL TESTING KITS, BY SAMPLE TYPE, 2022-2032 ($MILLION)
  • TABLE 132. UAE FUNGAL TESTING KITS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 133. UAE FUNGAL TESTING KITS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 134. ARGENTINA FUNGAL TESTING KITS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 135. ARGENTINA FUNGAL TESTING KITS, BY SAMPLE TYPE, 2022-2032 ($MILLION)
  • TABLE 136. ARGENTINA FUNGAL TESTING KITS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 137. ARGENTINA FUNGAL TESTING KITS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 138. REST OF LAMEA FUNGAL TESTING KITS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 139. REST OF LAMEA FUNGAL TESTING KITS, BY SAMPLE TYPE, 2022-2032 ($MILLION)
  • TABLE 140. REST OF LAMEA FUNGAL TESTING KITS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 141. REST OF LAMEA FUNGAL TESTING KITS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 142. MERCK KGAA: KEY EXECUTIVES
  • TABLE 143. MERCK KGAA: COMPANY SNAPSHOT
  • TABLE 144. MERCK KGAA: OPERATING SEGMENTS
  • TABLE 145. MERCK KGAA: PRODUCT PORTFOLIO
  • TABLE 146. MERCK KGAA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 147. THERMO FISHER SCIENTIFIC: KEY EXECUTIVES
  • TABLE 148. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
  • TABLE 149. THERMO FISHER SCIENTIFIC: OPERATING SEGMENTS
  • TABLE 150. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
  • TABLE 151. THERMO FISHER SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 152. BIOMERIEUX SA: KEY EXECUTIVES
  • TABLE 153. BIOMERIEUX SA: COMPANY SNAPSHOT
  • TABLE 154. BIOMERIEUX SA: OPERATING SEGMENTS
  • TABLE 155. BIOMERIEUX SA: PRODUCT PORTFOLIO
  • TABLE 156. BIOMERIEUX SA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 157. ELITECH GROUP: KEY EXECUTIVES
  • TABLE 158. ELITECH GROUP: COMPANY SNAPSHOT
  • TABLE 159. ELITECH GROUP: OPERATING SEGMENTS
  • TABLE 160. ELITECH GROUP: PRODUCT PORTFOLIO
  • TABLE 161. ELITECH GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 162. PERKINELMER: KEY EXECUTIVES
  • TABLE 163. PERKINELMER: COMPANY SNAPSHOT
  • TABLE 164. PERKINELMER: OPERATING SEGMENTS
  • TABLE 165. PERKINELMER: PRODUCT PORTFOLIO
  • TABLE 166. PERKINELMER: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 167. NORGEN BIOTEK: KEY EXECUTIVES
  • TABLE 168. NORGEN BIOTEK: COMPANY SNAPSHOT
  • TABLE 169. NORGEN BIOTEK: OPERATING SEGMENTS
  • TABLE 170. NORGEN BIOTEK: PRODUCT PORTFOLIO
  • TABLE 171. NORGEN BIOTEK: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 172. C.P.M DIAGNOSTIC RESEARCH SAS: KEY EXECUTIVES
  • TABLE 173. C.P.M DIAGNOSTIC RESEARCH SAS: COMPANY SNAPSHOT
  • TABLE 174. C.P.M DIAGNOSTIC RESEARCH SAS: OPERATING SEGMENTS
  • TABLE 175. C.P.M DIAGNOSTIC RESEARCH SAS: PRODUCT PORTFOLIO
  • TABLE 176. C.P.M DIAGNOSTIC RESEARCH SAS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 177. BIOMED DIAGNOSTICS, INC.: KEY EXECUTIVES
  • TABLE 178. BIOMED DIAGNOSTICS, INC.: COMPANY SNAPSHOT
  • TABLE 179. BIOMED DIAGNOSTICS, INC.: OPERATING SEGMENTS
  • TABLE 180. BIOMED DIAGNOSTICS, INC.: PRODUCT PORTFOLIO
  • TABLE 181. BIOMED DIAGNOSTICS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 182. F. HOFFMAN LA-ROCHE LTD.: KEY EXECUTIVES
  • TABLE 183. F. HOFFMAN LA-ROCHE LTD.: COMPANY SNAPSHOT
  • TABLE 184. F. HOFFMAN LA-ROCHE LTD.: OPERATING SEGMENTS
  • TABLE 185. F. HOFFMAN LA-ROCHE LTD.: PRODUCT PORTFOLIO
  • TABLE 186. F. HOFFMAN LA-ROCHE LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 187. HOLOGIC, INC.: KEY EXECUTIVES
  • TABLE 188. HOLOGIC, INC.: COMPANY SNAPSHOT
  • TABLE 189. HOLOGIC, INC.: OPERATING SEGMENTS
  • TABLE 190. HOLOGIC, INC.: PRODUCT PORTFOLIO
  • TABLE 191. HOLOGIC, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL FUNGAL TESTING KITS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL FUNGAL TESTING KITS MARKET
  • FIGURE 3. SEGMENTATION FUNGAL TESTING KITS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN FUNGAL TESTING KITS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALFUNGAL TESTING KITS MARKET
  • FIGURE 11. FUNGAL TESTING KITS MARKET SEGMENTATION, BY BY TEST TYPE
  • FIGURE 12. FUNGAL TESTING KITS MARKET FOR MOLECULAR TEST, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. FUNGAL TESTING KITS MARKET FOR CHROMOGENIC TEST, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. FUNGAL TESTING KITS MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. FUNGAL TESTING KITS MARKET SEGMENTATION, BY BY SAMPLE TYPE
  • FIGURE 16. FUNGAL TESTING KITS MARKET FOR SKIN, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. FUNGAL TESTING KITS MARKET FOR URINE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. FUNGAL TESTING KITS MARKET FOR VAGINAL SECRETION, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. FUNGAL TESTING KITS MARKET FOR BLOOD, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. FUNGAL TESTING KITS MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. FUNGAL TESTING KITS MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 22. FUNGAL TESTING KITS MARKET FOR RESEARCH, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. FUNGAL TESTING KITS MARKET FOR SUSCEPTIBILITY TESTING, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. FUNGAL TESTING KITS MARKET FOR MEDICAL DIAGNOSIS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. FUNGAL TESTING KITS MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 26. FUNGAL TESTING KITS MARKET SEGMENTATION, BY BY END USER
  • FIGURE 27. FUNGAL TESTING KITS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 28. FUNGAL TESTING KITS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 29. FUNGAL TESTING KITS MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 30. FUNGAL TESTING KITS MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 31. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 32. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 33. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 34. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 35. COMPETITIVE DASHBOARD
  • FIGURE 36. COMPETITIVE HEATMAP: FUNGAL TESTING KITS MARKET
  • FIGURE 37. Top player positioning, 2022
  • FIGURE 38. MERCK KGAA: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 39. MERCK KGAA: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 40. MERCK KGAA: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 41. THERMO FISHER SCIENTIFIC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 42. THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 43. THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 44. BIOMERIEUX SA: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 45. BIOMERIEUX SA: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 46. BIOMERIEUX SA: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 47. ELITECH GROUP: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 48. ELITECH GROUP: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 49. ELITECH GROUP: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 50. PERKINELMER: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 51. PERKINELMER: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 52. PERKINELMER: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 53. NORGEN BIOTEK: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 54. NORGEN BIOTEK: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 55. NORGEN BIOTEK: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 56. C.P.M DIAGNOSTIC RESEARCH SAS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 57. C.P.M DIAGNOSTIC RESEARCH SAS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 58. C.P.M DIAGNOSTIC RESEARCH SAS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 59. BIOMED DIAGNOSTICS, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 60. BIOMED DIAGNOSTICS, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 61. BIOMED DIAGNOSTICS, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 62. F. HOFFMAN LA-ROCHE LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 63. F. HOFFMAN LA-ROCHE LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 64. F. HOFFMAN LA-ROCHE LTD.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 65. HOLOGIC, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 66. HOLOGIC, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 67. HOLOGIC, INC.: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Fungal Testing Kits Market

Start reading.
This Report and over 66,905+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers